Andreas Halvorsen's CVS Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 3.66 M shares of CVS Health Corporation (CVS) worth $378.97 M, representing 1.08% of the portfolio. First purchased in 2018-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Andreas Halvorsen has maintained this position in CVS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 3.66 M shares. Largest reduction occurred in Q2 2018, reducing 950,311 shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +3.66 M | New Buy | 3.66 M | $103.45 |
| Q2 2018 | -950,311 | Sold Out | 0 | $0.00 |
| Q1 2018 | +950,311 | New Buy | 950,311 | $62.21 |
Andreas Halvorsen's CVS Health Corporation Investment FAQs
Andreas Halvorsen first purchased CVS Health Corporation (CVS) in Q1 2018, acquiring 950,311 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held CVS Health Corporation (CVS) for 3 quarters since Q1 2018.
Andreas Halvorsen's largest addition to CVS Health Corporation (CVS) was in Q2 2026, adding 3,663,361 shares worth $378.97 M.
According to the latest 13F filing for Q2 2026, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 3,663,361 shares of CVS Health Corporation (CVS), valued at approximately $378.97 M.
As of the Q2 2026 filing, CVS Health Corporation (CVS) represents approximately 1.08% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in CVS Health Corporation (CVS) was 3,663,361 shares, as reported at the end of Q2 2026.